A Key Preventive Measure

Vaccination

Canine Lyme disease is largely preventable through comprehensive control programs

Along with your client's efforts in helping to reduce environmental risk factors, a key preventive measure you can recommend is to vaccinate.

AAHA Vaccination Guidelines state that vaccination against canine Lyme disease is recommended for patients at specific risk for infection due to exposure or lifestyle. 7

Develop a canine Lyme disease prevention program in your clinic

A comprehensive canine Lyme disease prevention program in your clinic includes the following six steps:

  1. Test - Perform routine screening tests on all dogs for antibodies to Lyme disease especially if your clinic is in an endemic or expansion area.
  2. Examine - Perform a clinical exam and look for signs and symptoms of the disease.
  3. Probe - Talk to the client to uncover the dog's risk factors for Lyme disease.
  4. Treat - A positive test along with consistent presenting signs generally warrants a course of antibiotic treatment to clear the disease. It's up to the veterinarian to decide whether to treat a positive dog without signs.
  5. Vaccinate - After treating a positive, symptomatic dog, vaccinate to prevent future infections. In endemic and expansion canine Lyme disease areas, vaccinate all at-risk dogs annually, and make a canine Lyme vaccine part of the puppy series.
  6. Partner - Along with the client, develop an ongoing comprehensive tick-control program.

Annual wellness exams create good relationships

Staying in touch with clients and their dogs is important in maintaining the relationship, as well as the best way to provide preventive care for the dog. Implementing an annual, non-core canine Lyme vaccine into your clinic's protocol helps assure client compliance for an annual wellness exam.

Lyme disease
has been
found in all 10
Canadian
provinces
The threat of Lyme disease is probably greater in dogs than in humans
Dogs will often show no signs of Lyme disease
×

Disclaimer

You are now leaving the Boehringer Ingelheim (Canada) Ltd./Ltée [“BICL”] website. The linked site or any site associated with a link contained in a linked site is not under the control of BICL. BICL is not responsible for the contents of such site, any changes or updates to such site, or the collection and processing of any personal information from such site. Furthermore, BICL is not responsible for webcasting or any other form of transmission received from such site. This link is provided to you only as a convenience and the inclusion of any link does not imply endorsement of the site by BICL.

Cancel Continue